Key result
Selective pediatric lipid screening for familial hypercholesterolemia may optimize recommendations and reduce screening burden.
Why the study?
There is controversy and uncertainty about the benefits and harms of universal pediatric lipid screening for cardiovascular risk prevention starting early in life.
No takes yet. Share an insight, caveat, or question.
Targeted pediatric lipid screening may reduce burden; leaves open need for outcome trials before practice change.
Matthew W. Gillman (2012) conducted an editorial in Pediatric hypercholesterolemia. Selective pediatric lipid screening vs. Universal screening was evaluated. Shifting pediatric lipid screening from universal approaches to selectively detecting rare but severe conditions like familial hypercholesterolemia may improve recommendations and reduce burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: